The MPA approves start of clinical trial

  • 10:36

The Medical Products Agency approves Immunicum’s application to start a clinical phase I/II trial (EudraCT-nr 2011-002039-25) in renal cell carcinoma. The trial is expected to commence in Q1 2012.

Read the news in Nyteknik here.